Cite
HARVARD Citation
Ruella, M. et al. (2015). Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].